Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F List

Showing results (11-20 of 212) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|November 23, 2007
Lenalidomide--the phoenix risesAlan F List
Blood|June 26, 2004
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategiesDaruka Mahadevan, Alan F List
Hematology. American Society of Hematology. Education Program|November 21, 2007
Management of RBC-transfusion dependenceMagda Melchert, Alan F List
Current Hematology Reports|October 20, 2005
Cytokine targets in the treatment of myelodysplastic syndromesAmit Verma, Alan F List
International Journal of Hematology|December 7, 2007
Immunomodulatory therapy for myelodysplastic syndromesLubomir Sokol, Alan F List
Current Pharmaceutical Biotechnology|November 2, 2006
Immunomodulatory drugs (IMiDs): a new treatment option for myelodysplastic syndromesVishakha Kale, Alan F List
Current Pharmaceutical Design|May 11, 2012
Lenalidomide for treatment of myelodysplastic syndromesRami S Komrokji, Alan F List
Clinical Lymphoma & Myeloma|June 16, 2009
Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomideSandra E Kurtin, Alan F List
Seminars in Oncology|September 28, 2011
Role of lenalidomide in the treatment of myelodysplastic syndromesRami S Komrokji, Alan F List
Hematology/Oncology Clinics of North America|April 3, 2010
Lenalidomide for treatment of myelodysplastic syndromes: current status and future directionsRami S Komrokji, Alan F List
Pageof 22

Showing results (11-20 of 212) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|November 23, 2007
Lenalidomide--the phoenix risesAlan F List
Blood|June 26, 2004
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategiesDaruka Mahadevan, Alan F List
Hematology. American Society of Hematology. Education Program|November 21, 2007
Management of RBC-transfusion dependenceMagda Melchert, Alan F List
Current Hematology Reports|October 20, 2005
Cytokine targets in the treatment of myelodysplastic syndromesAmit Verma, Alan F List
International Journal of Hematology|December 7, 2007
Immunomodulatory therapy for myelodysplastic syndromesLubomir Sokol, Alan F List
Current Pharmaceutical Biotechnology|November 2, 2006
Immunomodulatory drugs (IMiDs): a new treatment option for myelodysplastic syndromesVishakha Kale, Alan F List
Current Pharmaceutical Design|May 11, 2012
Lenalidomide for treatment of myelodysplastic syndromesRami S Komrokji, Alan F List
Clinical Lymphoma & Myeloma|June 16, 2009
Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomideSandra E Kurtin, Alan F List
Seminars in Oncology|September 28, 2011
Role of lenalidomide in the treatment of myelodysplastic syndromesRami S Komrokji, Alan F List
Hematology/Oncology Clinics of North America|April 3, 2010
Lenalidomide for treatment of myelodysplastic syndromes: current status and future directionsRami S Komrokji, Alan F List
Pageof 22